ABN
Also have a "google" around unconcionable conduct
It is mighty illuminating
If a weaker party is under a disadvantage there is a postive onus on the stronger party to fully disclose all the facts and the weaker party should have independant legal advice
The disadvantage can be "being mislead"
The disadvantage also is the "density and legalese of the Amsla"
Another test..would a person of right mind (equiped with the full facts ..ever enter the contract)
The Courts reverse the onus onto the stronger party to have to prove the arrangements are fair and not one sided
ANZ/Opes spells unconcionable
When this thing is finally tested my view it will be U + M and D
Further when under s52 ..all the plaintiff has to show is M+D and they relied on it...thats easy
Then the Courts reverse the onus on to the defendant evidence that they took steps to recitfy M+D +U
Impossible for both ANZ and Opes ..in my view
- Forums
- ASX - By Stock
- for opes affected members
ANZ
anz group holdings limited
Add to My Watchlist
0.80%
!
$30.32

ABNAlso have a "google" around unconcionable conductIt is mighty...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$30.32 |
Change
0.240(0.80%) |
Mkt cap ! $90.46B |
Open | High | Low | Value | Volume |
$30.08 | $30.42 | $30.00 | $145.0M | 4.795M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 270 | $30.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$30.36 | 1001 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 270 | 30.310 |
1 | 33 | 30.300 |
1 | 750 | 30.280 |
1 | 1000 | 30.240 |
1 | 1000 | 30.200 |
Price($) | Vol. | No. |
---|---|---|
30.400 | 5535 | 4 |
30.410 | 3000 | 1 |
30.420 | 1250 | 3 |
30.430 | 55000 | 2 |
30.440 | 1458 | 2 |
Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
Featured News
ANZ (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online